|Articles|August 25, 2022
Genetic insights for biopharmaceuticals: Propelling drug candidates into therapeutic assets
Author(s)Thermo Fisher
For biopharmaceutical developers, optimizing R&D investment in new technologies is an essential way to gain and sustain a competitive edge. Clinical trials present a tremendous opportunity to leverage advanced genetics technologies and practices to improve efficiency and reduce costs.
Trending on PharmExec
1
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
2
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
3
From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection
4
Pharmaceutical Executive Daily: FDA Grants Traditional Approval to Novartis's Fabhalta
5